Trident Texofab Limited (TTFL.BO)

INR 158.75

(1.99%)

Annual Income Statements

(In INR)
Breakdown 2024 2023 2022 2021 2020
Revenue 994.83 Million 963.56 Million 842.93 Million 499.26 Million 909.64 Million
Cost of Revenue 850.51 Million 803.87 Million 722.55 Million 424.63 Million 787.79 Million
Gross Profit 144.32 Million 159.68 Million 120.37 Million 74.62 Million 121.84 Million
Operating Expenses 27.09 Million 113.04 Million 87.18 Million 56.06 Million 70.17 Million
Selling, General and Administrative Expenses 27.09 Million 28.01 Million 4.54 Million 4.16 Million 3.84 Million
Research and Development Expenses - - 35 Thousand 21 Thousand -
Other Expenses - 19.03 Million 7.41 Million 2.05 Million -
Cost and Expenses 865.46 Million 916.92 Million 809.73 Million 480.7 Million 857.97 Million
Operating Income 129.36 Million 65.67 Million 40.6 Million 36.41 Million 51.35 Million
Interest Expense 57.28 Million 37.11 Million 28.29 Million 27.85 Million 26.87 Million
Income Tax Expense 889 Thousand 5.07 Million 2.9 Million 5.51 Million 6.28 Million
Earnings before Tax 11.68 Million 27.26 Million 12.73 Million 9.04 Million 15.29 Million
Net Income 10.79 Million 22.18 Million 9.82 Million 3.53 Million 9 Million
Earnings Per Share Basic 1.07 2.20 0.98 0.35 0.90
Earnings Per Share Diluted 1.07 2.20 0.98 0.35 0.90
Weighted Average Shares Outstanding 10.09 Million 10.08 Million 10.02 Million 9.99 Million 9.99 Million
Weighted Average Shares Outstanding (Diluted) 10.09 Million 10.08 Million 10.02 Million 9.99 Million 9.99 Million
Gross Margin 0.15 0.17 0.14 0.15 0.13
EBIT Margin 0.09 0.09 0.07 0.09 0.07
Profit Margin 0.01 0.02 0.01 0.01 0.01
EBITDA 85.46 Million 99.33 Million 67.36 Million 47.13 Million 59.4 Million
Earnings Before Tax Margin 0.13 0.07 0.05 0.07 0.06

Income Statement Charts